Eopinex Ltd 12939628 false 2023-11-01 2024-10-31 2024-10-31 The principal activity of the company is to provide medical services. Digita Accounts Production Advanced 6.30.9574.0 true 12939628 2023-11-01 2024-10-31 12939628 2024-10-31 12939628 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 12939628 bus:Micro-entities 2023-11-01 2024-10-31 12939628 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 12939628 bus:FullAccounts 2023-11-01 2024-10-31 12939628 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 12939628 bus:RegisteredOffice 2023-11-01 2024-10-31 12939628 bus:Director1 2023-11-01 2024-10-31 12939628 bus:Director2 2023-11-01 2024-10-31 12939628 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 12939628 countries:England 2023-11-01 2024-10-31 12939628 2022-11-01 2023-10-31 12939628 2023-10-31 12939628 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 iso4217:GBP xbrli:pure

Registration number: 12939628

Eopinex Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 October 2024

 

Eopinex Ltd

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

1

 

Eopinex Ltd

(Registration number: 12939628)
Balance Sheet as at 31 October 2024

2024
£

2023
£

Current assets

228,849

217,117

Creditors: Amounts falling due within one year

(54,122)

(84,065)

Total assets less current liabilities

174,727

133,052

Accruals and deferred income

(1,950)

(1,950)

 

172,777

131,102

Capital and reserves

172,777

131,102

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
80-83 Long Lane
London
EC1A 9ET
United Kingdom

These financial statements were authorised for issue by the Board on 20 January 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

For the financial year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 20 January 2025 and signed on its behalf by:
 

 

Eopinex Ltd

(Registration number: 12939628)
Balance Sheet as at 31 October 2024

.........................................
Mahinda Yogarajah
Director

.........................................
Dominic Paviour
Director